Patents by Inventor Thomas P. Hedman

Thomas P. Hedman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9918870
    Abstract: A method of treating snoring and/or OSA in a subject in need of such treatment. The method includes crosslinking proteins of the subject's soft palate tissue or pharynx tissue. The crosslinking can occur by contacting the soft palate or pharynx tissue with a crosslinking reagent. In addition, the crosslinking can occur without heating, contracting or denaturing of the tissue, or any combination thereof.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: March 20, 2018
    Assignee: Orthopeutics, L.P.
    Inventors: Thomas P. Hedman, Pawel Slusarewicz
  • Publication number: 20170354637
    Abstract: The present invention relates to administration or application of a crosslink inducing agent to a subject following a stiffening procedure to the respiratory system. The present invention has identified that such application or administration of a crosslinking reagent to fibrotic tissue allows for improved stability and strength of the tissue.
    Type: Application
    Filed: June 13, 2016
    Publication date: December 14, 2017
    Inventors: Matthew E. Brown, Thomas P. Hedman
  • Patent number: 9492592
    Abstract: A method of treating a tear in a knee meniscus of a patient. The method includes exposing the torn knee meniscus to a protein crosslinker during surgery to repair the tear. Also provided is a fixation device for the surgical repair of tears of the meniscus of the knee, where the device contains one or more protein crosslinking reagents.
    Type: Grant
    Filed: April 13, 2015
    Date of Patent: November 15, 2016
    Assignee: Orthopeutics, L. P.
    Inventors: Thomas P. Hedman, Pawel Slusarewicz
  • Publication number: 20160015555
    Abstract: A method of treating snoring and/or OSA in a subject in need of such treatment. The method includes crosslinking proteins of the subject's soft palate tissue or pharynx tissue. The crosslinking can occur by contacting the soft palate or pharynx tissue with a crosslinking reagent. In addition, the crosslinking can occur without heating, contracting or denaturing of the tissue, or any combination thereof.
    Type: Application
    Filed: September 29, 2015
    Publication date: January 21, 2016
    Applicant: Orthopeutcs. L.P.
    Inventors: Thomas P. Hedman, Pawel Slusarewicz
  • Patent number: 9192507
    Abstract: A method of treating snoring and/or OSA in a subject in need of such treatment. The method includes crosslinking proteins of the subject's soft palate tissue or pharynx tissue. The crosslinking can occur by contacting the soft palate or pharynx tissue with a crosslinking reagent. In addition, the crosslinking can occur without heating, contracting or denaturing of the tissue, or any combination thereof.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: November 24, 2015
    Assignee: Orthopeutics, L.P.
    Inventors: Thomas P. Hedman, Pawel Slusarewicz
  • Patent number: 9101602
    Abstract: A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. The crosslinking reagent includes a crosslinking agent such as genipin and/or proanthrocyanidin. Further, the crosslinking reagent may include a crosslinking agent in a carrier medium. The collagenous tissue to be contacted with the crosslinking reagent is preferably a portion of an intervertebral disc or articular cartilage. The contact between the tissue and the crosslinking reagent is effected by injections directly into the select tissue using a needle. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system such as a gel or ointment, or a treated membrane or patch directly into or onto the target tissue. Contact may also be effected by, for instance, soaking.
    Type: Grant
    Filed: December 13, 2010
    Date of Patent: August 11, 2015
    Assignee: Orthopeutics L.P.
    Inventor: Thomas P. Hedman
  • Publication number: 20150217025
    Abstract: A method of treating a tear in a knee meniscus of a patient. The method includes exposing the torn knee meniscus to a protein crosslinker during surgery to repair the tear. Also provided is a fixation device for the surgical repair of tears of the meniscus of the knee, where the device contains one or more protein crosslinking reagents.
    Type: Application
    Filed: April 13, 2015
    Publication date: August 6, 2015
    Applicant: Orthopeutics, L.P.
    Inventors: Thomas P. Hedman, Paul Slusarewicz
  • Patent number: 9084772
    Abstract: A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. The crosslinking reagent includes a crosslinking agent such as genipin and/or proanthrocyanidin. Further, the crosslinking reagent may include a crosslinking agent in a carrier medium. The collagenous tissue to be contacted with the crosslinking reagent is preferably a portion of an intervertebral disc or articular cartilage. The contact between the tissue and the crosslinking reagent is effected by injections directly into the select tissue using a needle. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system such as a gel or ointment, or a treated membrane or patch directly into or onto the target tissue. Contact may also be effected by, for instance, soaking.
    Type: Grant
    Filed: August 29, 2002
    Date of Patent: July 21, 2015
    Assignee: Orthopeutics L.P.
    Inventor: Thomas P. Hedman
  • Patent number: 8450276
    Abstract: A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. Methods and devices for enhancing the body's own efforts to stabilize discs in scoliotic spines by increasing collagen crosslinks. This stability enhancement is caused by reducing the bending hysteresis and increasing the bending stiffness of scoliotic spines, by injecting non-toxic crosslinking reagents into the convex side of discs involved in the scoliotic curve. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system directly into or onto the target tissue.
    Type: Grant
    Filed: June 16, 2010
    Date of Patent: May 28, 2013
    Assignee: Orthopeutics L.P.
    Inventor: Thomas P. Hedman
  • Publication number: 20130087155
    Abstract: A method of treating snoring and/or OSA in a subject in need of such treatment. The method includes crosslinking proteins of the subject's soft palate tissue or pharynx tissue. The crosslinking can occur by contacting the soft palate or pharynx tissue with a crosslinking reagent. In addition, the crosslinking can occur without heating, contracting or denaturing of the tissue, or any combination thereof.
    Type: Application
    Filed: June 28, 2011
    Publication date: April 11, 2013
    Applicant: ORTHOPEUTICS, L.P.
    Inventors: Thomas P. Hedman, Pawel Slusarewicz
  • Publication number: 20130085569
    Abstract: A method of treating a tear in a knee meniscus of a patient. The method includes exposing the torn knee meniscus to a protein crosslinker during surgery to repair the tear. Also provided is a fixation device for the surgical repair of tears of the meniscus of the knee, where the device contains one or more protein crosslinking reagents.
    Type: Application
    Filed: May 26, 2011
    Publication date: April 4, 2013
    Applicant: Orthopeutics, L.P.
    Inventors: Thomas P. Hedman, Paul Slusarewicz
  • Patent number: 8283322
    Abstract: Improved methods and compositions for the treatment of native tissues with crosslinkers are provided. The methods and compositions will find particular use in increasing resistance to tearing, fissuring, rupturing, and/or delamination.
    Type: Grant
    Filed: July 1, 2009
    Date of Patent: October 9, 2012
    Assignee: Orthopeutics, LP
    Inventors: Paul Slusarewicz, Thomas P. Hedman
  • Patent number: 8211938
    Abstract: A method of treatment of native, non-denatured tissue to increase resistance to tearing, fissuring, rupturing, and/or delamination, comprising the step of: contacting at least a portion of the tissue with an effective amount of a reagent that increases crosslinks in the tissue.
    Type: Grant
    Filed: March 2, 2010
    Date of Patent: July 3, 2012
    Assignee: Orthopeutics, L.P.
    Inventor: Thomas P. Hedman
  • Patent number: 8198248
    Abstract: Improved methods and compositions for the treatment of native tissues with crosslinkers are provided. The methods and compositions will find particular use in increasing resistance to tearing, fissuring, rupturing, and/or delamination.
    Type: Grant
    Filed: September 3, 2008
    Date of Patent: June 12, 2012
    Assignee: Orthopeutics, LP
    Inventors: Thomas P. Hedman, Paul Slusarewicz
  • Patent number: 8153600
    Abstract: A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. Methods and devices for enhancing the body's own efforts to stabilize discs in scoliotic and other progressively deforming spines by increasing collagen crosslinks. This stability enhancement is caused by reducing the bending hysteresis and increasing the elasticity and bending stiffness of progressively deforming spines, by injecting non-toxic crosslinking reagents into the convex side of discs involved in the potential or progressing deformity curve. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system directly into or onto the target tissue.
    Type: Grant
    Filed: February 2, 2006
    Date of Patent: April 10, 2012
    Assignee: Orthopeutics, L.P.
    Inventor: Thomas P. Hedman
  • Patent number: 8119599
    Abstract: A method of treatment of native, non-denatured tissue to increase resistance to tearing, fissuring, rupturing, and/or delamination, comprising the step of: contacting at least a portion of the tissue with an effective amount of a reagent that increases crosslinks in the tissue.
    Type: Grant
    Filed: October 17, 2007
    Date of Patent: February 21, 2012
    Assignee: Orthopeutics, L.P.
    Inventors: Thomas P. Hedman, Paul Slusarewicz
  • Patent number: 8022101
    Abstract: A method of treatment of native, non-denatured tissue to increase resistance to tearing, fissuring, rupturing, and/or delamination, comprising the step of: contacting at least a portion of the tissue with an effective amount of a reagent that increases crosslinks in the tissue.
    Type: Grant
    Filed: February 28, 2007
    Date of Patent: September 20, 2011
    Assignee: Orthopeutics, L.P.
    Inventor: Thomas P. Hedman
  • Publication number: 20110082199
    Abstract: A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. The crosslinking reagent includes a crosslinking agent such as genipin and/or proanthrocyanidin. Further, the crosslinking reagent may include a crosslinking agent in a carrier medium. The collagenous tissue to be contacted with the crosslinking reagent is preferably a portion of an intervertebral disc or articular cartilage. The contact between the tissue and the crosslinking reagent is effected by injections directly into the select tissue using a needle. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system such as a gel or ointment, or a treated membrane or patch directly into or onto the target tissue. Contact may also be effected by, for instance, soaking.
    Type: Application
    Filed: December 13, 2010
    Publication date: April 7, 2011
    Inventor: Thomas P. Hedman
  • Publication number: 20100266544
    Abstract: A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. Methods and devices for enhancing the body's own efforts to stabilize discs in scoliotic spines by increasing collagen crosslinks. This stability enhancement is caused by reducing the bending hysteresis and increasing the bending stiffness of scoliotic spines, by injecting non-toxic crosslinking reagents into the convex side of discs involved in the scoliotic curve. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system directly into or onto the target tissue.
    Type: Application
    Filed: June 16, 2010
    Publication date: October 21, 2010
    Inventor: Thomas P. Hedman
  • Publication number: 20100158887
    Abstract: A method of treatment of native, non-denatured tissue to increase resistance to tearing, fissuring, rupturing, and/or delamination, comprising the step of: contacting at least a portion of the tissue with an effective amount of a reagent that increases crosslinks in the tissue.
    Type: Application
    Filed: March 2, 2010
    Publication date: June 24, 2010
    Inventor: Thomas P. Hedman